Exercise Immunologist, Adjunct A/Professor at Duke University, Senior Lecturer & Head of SES Research at the University of Surrey. Views are my own.
Guildford, England
Joined April 2018
- Tweets1.2K
- Following839
- Followers597
- Likes1.8K
David Bartlett, PhD retweeted
✨ Save the date - The Purple Ball is back! ✨
Join us on Saturday 14th November at the Harbour Hotel, Guildford for a fantastic evening raising money for Topic of Cancer.
We're also looking for raffle prize donations to help make the night a success.
Super excited. Heading to the British Society for Haematology (#BSH2026) conference in Liverpool. Can't wait to present our exercise trial in #CLL, run by the amazing @EllieeMiles, and talk about the use of Exercise Immunology in Blood Cancer. @UniSurreyBioSci @CLLSupport
David Bartlett, PhD retweeted
All systems go.
Ready to begin a full-on CLL scientific day in central London.
#CLL
David Bartlett, PhD retweeted
Researchers explored whether a quick, 30-second handgrip task could capture subjective fatigue, the kind you notice during training, work, or daily life.
👉 Swipe to test your intuition. Would you expect a simple strength task to tell the full story?
#AEHS #Exercise #Fatigue
David Bartlett, PhD retweeted
Thank you to everyone who joined us at the Purple Ball! It was a wonderful evening with many new faces, and together we raised £11,000 for Topic of Cancer. We’re so grateful for your support and generosity. 💜 #PurpleBall #TopicOfCancer
David Bartlett, PhD retweeted
Nature research paper: Tumour-reactive heterotypic CD8 T cell clusters from clinical samples
go.nature.com/4oTSupN
David Bartlett, PhD retweeted
Online Now: A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma dlvr.it/TPRhN2
David Bartlett, PhD retweeted
We’re so grateful to everyone who gets involved and supports Topic of Cancer - from runners and volunteers to donors and event guests. Together, we’re funding research that gives hope.
Read more about Topic of Cancer on our website here: topicofcancer.org.uk/
David Bartlett, PhD retweeted
Our free ToCFit exercise sessions help cancer patients and survivors build strength and confidence in a relaxed, friendly environment. No pressure, just support.
For more details, email chair@topicofcancer.org.uk
David Bartlett, PhD retweeted
Every donation helps us fund innovative immunotherapy research and support people living with cancer. It’s your generosity that drives change.
topicofcancer.org.uk/donate/
#TopicOfCancer #ImmunotherapyResearch #CancerTreatmentResearch #GuildfordCharity
Brilliant to see our work @UniSurreyBioSci and @DukeCancer in the #CLL UK guidelines for the first time advising physical activity and exercise for patients with chronic lymphocytic leukaemia 😀. #exerciseoncology @BrJHaem
onlinelibrary.wiley.com/doi/…
David Bartlett, PhD retweeted
We’re so proud of Therese, who has completed her 10K run to raise funds for Topic of Cancer!
As an oesophageal cancer patient, Therese has personally benefitted from the research carried out by the Oncology Research Team, including the exercise-based studies supported ... 1/2
David Bartlett, PhD retweeted
Cool presentation that shows that in 75% of pts with IgM and CLL, the CLL is producing the IgM (I.e. the MGUS is not a separate process) #iwCLL2025
David Bartlett, PhD retweeted
Effects of lactate concentration on T‐cell phenotype and mitochondrial respiration - Cho - 2025 - Physiological Reports - Wiley Online Library physoc.onlinelibrary.wiley.c…
David Bartlett, PhD retweeted
🫁 New research: Just 10 weeks of training can boost lung function in kids with cystic fibrosis.
✅ Endurance
✅ Resistance
✅ Best of all? Concurrent training 💪
Improved pulmonary function & quality of life. Exercise is medicine.
#CysticFibrosis #PedsCare #ClinicalTrials
Great work from my PhD student @EllieeMiles on her 1st of many papers on #CLL in @e_JHaem. She shows that being physically active with CLL is associated with better QoL & reduced symptoms of CLL, including fatigue, pain, and physical limitations.
onlinelibrary.wiley.com/doi/…
David Bartlett, PhD retweeted
'Exercise during chemotherapy may help immune cells fight cancer'
Learn more about this research, which Topic of Cancer has proudly supported, a first-of-its-kind pilot study from @UniOfSurrey and @RoyalSurrey
medicalxpress.com/news/2025-…
David Bartlett, PhD retweeted
Honoured to present our from the i3 collaborative w/ @UTSEngage work using #DigitalTech to support independence & wellbeing in #AdvancedCancer
Great questions & discussions, so grateful to share & learn w/ the #MASCC community!
#DigitalHealth #CancerCare #SupportiveOncology
David Bartlett, PhD retweeted
Presented at #EHA2025:
Among patients with chronic lymphocytic leukemia, undetectable MRD and progression-free survival were more common with ibrutinib–venetoclax than with ibrutinib alone or chemoimmunotherapy, with benefits sustained at 5 years.
Full FLAIR phase 3 trial results: nej.md/3SMNdC4
@eha_hematology
ALT A graph showing progression-free survival estimates among all participants.
David Bartlett, PhD retweeted
CLL13 longer follow up - huge study and great presentation. Though GIV is superior, I would not use as SOC since the duration of therapy is longer (range 12-36 months) than ven/obi which is still quite excellent (and always 1 yr). And yes MRD still matters! #EHA25 #EHA2025
